Zimmer Biomet Holdings, Inc. ZBH
Set alert
At close · Nov 2
After hours · Nov 2, 6:40 PM ET
- YTD
- +8.26%
- 1 year
- -3.19%
- Open
- 95.09
- Prev close
- 94.52
- Mkt cap
- 18.57B
- Vol
- 2.58M
- Avg vol
- 2.08M
- EPS
- 4.12
- P/E
- 23.63
- Div yield
- 1.02%
More statistics
- Low
- 94.50
- High
- 97.35
- Forward P/E
- 10.75
- Beta
- 0.47
- Short ratio
- 3.64
- Inst. own
- 111.30%
- Dividend
- 0.96
- Ex-div date
- Sep 29, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 94.85
- 200-d avg
- 91.63
- 1y target
- 106.90
5D chart
Signals (132)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 3:25 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 3:20 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 3:00 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 2:20 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:45 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:35 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 12:55 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 12:45 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 12:05 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 11:55 AM | 14 hours ago |
| RSI: Overbought | Nov 2, 11:20 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 10:30 AM | 16 hours ago |
Newest 20 of 132.
News
4 days ago zacks.com
Zimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?
ZBH heads into Q3 earnings with growth expected in Hips, S.E.T. and Technology & Data, while Knee sales face ongoing pressure.
4 days ago zacks.com
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 days ago prnewswire.com
Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026
Featured symposium will reveal a new vision for intelligent systems that support surgeon judgment, reduce procedural burden and connect the episode of care WARSAW, Ind., Oct. 29, 2026 /PRNewswire/ --…
-
1 week ago benzinga.com
Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target
Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.
-
2 weeks ago benzinga.com
Zimmer Biomet Expands Its Distribution, Supply Deal With THINK Surgical To Continue Distribution Of THINK's Wireless TMINI Miniature Robotic System
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year…
2 weeks ago prnewswire.com
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Multi-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI® System for Use with Zimmer Biomet's Persona® Knee System FREMONT, Calif. and WARSAW, Ind.
3 weeks ago zacks.com
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
3 weeks ago benzinga.com
Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
Michael Burry calls Anthropic's valuation a 'bubble,' noting it could buy 78 profitable S&P 500 companies like Domino's and Clorox.
3 weeks ago zacks.com
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.
3 weeks ago prnewswire.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
WARSAW, Ind., Oct. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be…
3 weeks ago defenseworld.net
Critical Review: Zimmer Biomet (NYSE:ZBH) and Butterfly Network (NYSE:BFLY)
Zimmer Biomet (NYSE: ZBH - Get Free Report) and Butterfly Network (NYSE: BFLY - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses…
1 month ago defenseworld.net
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shareholders to Get $0.24 Quarterly Dividend
Zimmer Biomet Holdings, Inc. (NYSE: ZBH - Get Free Report) declared a quarterly dividend on Friday, August 28th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.24…
1 month ago defenseworld.net
Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp
State Street Corp boosted its holdings in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 0.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and…
1 month ago zacks.com
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
1 month ago defenseworld.net
Critical Contrast: Zimmer Biomet (NYSE:ZBH) versus CapsoVision (NASDAQ:CV)
Zimmer Biomet (NYSE: ZBH - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on…
1 month ago gurufocus.com
Is Zimmer Biomet Holdings Inc (ZBH) a Bargain After 3.9% Drop? GF Value Says Undervalued
On September 08, 2026, Zimmer Biomet Holdings Inc (ZBH) shares fell 3.9% to a current price of $94.22. This decline comes amid a 52-week price range of $79.12 t
1 month ago prnewswire.com
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and…
1 month ago zacks.com
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
1 month ago defenseworld.net
25,021 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Jupiter Topco LLC
Jupiter Topco LLC purchased a new stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The…
2 months ago seekingalpha.com
Zimmer Biomet - Showing Signs Of Life
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should…
2 months ago zacks.com
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2 months ago prnewswire.com
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment…
2 months ago zacks.com
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.
-
2 months ago benzinga.com
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.
-
2 months ago benzinga.com
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
-
2 months ago benzinga.com
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
-
2 months ago benzinga.com
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
-
2 months ago benzinga.com
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.
-
2 months ago benzinga.com
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553…
-
2 months ago benzinga.com
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $2.01 by 2.99 percent. This is unchanged from the same period last year.…
4 months ago benzinga.com
AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today
Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end
-
4 months ago benzinga.com
Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140M
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the divestiture of…
5 months ago benzinga.com
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.
6 months ago benzinga.com
Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama
Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies above $99 and the Fed's two-day meeting kicks off.
6 months ago benzinga.com
Earnings Scheduled For April 28, 2026
Earnings Scheduled For April 28, 2026
7 months ago benzinga.com
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See what analysts think of these stocks.
-
8 months ago benzinga.com
Earnings Scheduled For February 10, 2026
Earnings Scheduled For February 10, 2026
10 months ago benzinga.com
This Illinois Tool Works Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
This Illinois Tool Works Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
12 months ago benzinga.com
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be…
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
-
1 year ago benzinga.com
Treace Medical Concepts Files Patent Infringement Lawsuit Against Zimmer Biomet And Paragon 28, Alleging Violation Of 4 Patents Related To Its Lapiplasty 3D Bunion Correction Technologies And Seeking Injunctive Relief And Damages
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities…
1 year ago benzinga.com
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.
1 year ago benzinga.com
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged…
-
1 year ago benzinga.com
Earnings Scheduled For February 6, 2025
Earnings Scheduled For February 6, 2025
-
2 years ago benzinga.com
NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S. Distribution And Certain OUS Markets
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitabilityEDEN PRAIRIE, Minn., Oct. 31, 2024…
-
2 years ago benzinga.com
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
-
2 years ago benzinga.com
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday